Narayana Hrudayalaya Tissue Bank&Stem Cell Research Center, Bangalore

Home | About Us | Contact Us | FAQ's | Sitemap | Login

HOME|INFORMATION|PROGRAM & MANAGEMENT|SPONSORS|EDUCATION|TARIFF|EMPLOYMENT

What are Stem Cells?

Private Banking Services

Public Banking Services

Clinical Conditions that are treatable by Stem Cells

Discussion Board

Upcomming Events

Training Programmes

Collaboration for Translational Research

Why Bank with Us:{HEART-Hospital Based | Exclusivity, Expertise and Efficiency | Affordability | Reliability | Treatment >> MYTH1 Stem cells in umbilical cord blood is a recent discovery. >> FACT Haematopoietic stem cells were first found in human umbilical cord blod in 1978. In the ast 30 years much progress has been made and more and more people are collecting their child's umbilical cord blood either for donation or to save for the future. >> MYTH 2 As an expectant mother i don't need further education on stem cells. I already know everything about umbilical cord blood storage options. >> FACT Study reveals that only 14% of patients are educated by their healthcare provider on cord blood banking options. It further states that 63% of patients have "some Knowledge", 74% are minimally informed, while 37% have no knowledge about the subject.

Welcome to Narayana Hrudayalaya Tissue Bank & Stem Cell Research Center

Further Information
Name
Email Id
Contact
Expected Date of Delivery
Place
Private Banking / Donation

Narayana Hrudayalaya Tissue Bank and Stem Cell Research Center (NHTB-SCRC) is a joint venture between Rotary Bangalore Health City (RBHC) and Narayana Hrudayalaya. NHTB-SCRC is located in the health city campus on Hosur Road 16 kms from the Silk Board Junction and 4 kms after the Electronic City.

Our mission is to create awareness on Cord Blood Banking among the masses. Our vision is to make sure that every pregnant mother in India is able to afford to bank her child’s cord blood and cord tissue in a novel form of “Biological Insurance”.

The center would also assist in research and development of newer stem cell therapies.

These goals are met while ensuring patient safety and well being by maintaining compliance with ICMR guidelines, Good Manufacturing Practice (GMP) guidelines, strict confidentiality and adherence to ethical standards.